Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Prostate Cancer Treatment and Research, PARP inhibition in cancer therapy, Cancer-related Molecular Pathways, and Cancer Genomics and Diagnostics.
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer
N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling
Dual Roles of PARP-1 Promote Cancer Growth and Progression